Skip to main content
Log in

Comparative antibacterial activity of the new cephalosporin cefcanel against anaerobic bacteria

  • New Antimicrobial Agents
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

Abstract

The activity of cefcanel against anaerobic cocci,Clostridium perfringens, Bacteroides fragilis, Bacteroides spp. and fusobacteria was determined by the agar dilution method and compared with the activity of cefaclor, cephalexin, cefadroxil, phenoxymethylpenicillin and ampicillin. Cefcanel showed good activity againstClostridium perfringens, Bacteroides spp. and fusobacteria (MIC90=1–4 mg/l). Against anaerobic cocci its MIC90 value was 16 mg/l, and againstBacteroides fragilis, 32 mg/l. Cefcanel has an antibacterial activity that warrants investigation in clinical trials.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Holdeman, L. V., Cato, E. P., Moore, W. E. C.: Anacrobe laboratory manual. Virginia Polytechnic Institute and State University, Blacksburg, VA, 1977.

    Google Scholar 

  2. Dornbusch, K., Nord, C. E., Olsson-Liljequist, B.: Antibiotic susceptibility of anaerobic bacteria with special reference toBacteroides fragilis. Scandinavian Journal of Infectious Diseases 1979, 19: 17–25.

    PubMed  Google Scholar 

  3. Olsson, B., Dornbusch, K., Nord, C. E.: Susceptibility to beta-lactam antibiotics and production of beta-lactamase inBacteroides fragilis. Medical Microbiology and Immunology 1979, 163: 183–194.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nord, C.E., Lindmark, A. & Persson, I. Comparative antibacterial activity of the new cephalosporin cefcanel against anaerobic bacteria. Eur. J. Clin. Microbiol. Infect. Dis. 8, 550–551 (1989). https://doi.org/10.1007/BF01967478

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01967478

Keywords

Navigation